Liraglutide: another reason to target prediabetes?

Oncotarget. 2017 Nov 1;8(59):99203-99204. doi: 10.18632/oncotarget.22256. eCollection 2017 Nov 21.

Authors

Conor F Murphy¹, Neil G Docherty¹, Carel W le Roux¹

Affiliation

¹ Carel W. le Roux: Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland and Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

No abstract available

Keywords: GLP-1; SCALE; liraglutide; obesity; prediabetes.

Publication types

Editorial